Running clinical trials is an orchestrated process — trust The PharmaKon LLC to conduct every trial with operational excellence. The PharmaKon LLC partners with biopharmaceutical and biotech companies, investigators, site staff, lab and technology vendors, and regulatory authorities to reinforce patient safety and access throughout every phase of research. All play a part in delivering the quality data that can drive promising compounds forward.
Government and nonprofit agencies require a partner that understands their specific requirements, has experience working within this sector, and can meet the unique needs of these various agencies and programs.
For nearly 30 years, PharmaKon’s dedicated government and public health services group have successfully delivered clinical research services to various agencies, contractors, and nonprofits in both prime contractor and subcontractor capacities within full compliance of all federal contracting requirements. Our services have supported the organizations in conducting therapeutic, vaccine, and medical device studies on a global scale across all trial phases and therapeutic areas.
Patient Solutions for Clinical Trials
To meet the unique needs of the various government agencies and programs, we offer quality performance and innovation. We offer innovative trial design and technology offerings such as
Feasibility
Regulatory
Study startup
Recruitment
Clinical research units (for healthy and patient volunteers)
IXRS
Monitoring
Medical monitoring and PVG
Patient preference studies
Data management
Biostatistics
Pharmacokinetics and pharmacodynamics
Quality Assurance Auditing
Medical writing
Medical communications
Modeling and simulation
Systematic literature reviews, network meta-analyses, simulated and indirect treatment comparisons
In the past 5 years: 800+ trials with dedicated team members including remote locations
Major Pharmaceutical Business - Clinical trials, phases 1 & 2, 5-year projects, long term follow up, ongoing - $16.5 million gross revenue
Sub-Contractor Cooperative Group - Clinical trials - 5-year projects, long term follow up, ongoing - $17.5 million gross revenue